Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by pierre013on Apr 01, 2015 6:33pm
328 Views
Post# 23589259

Carefulness is required

Carefulness is requiredA lot of opinions about the consolidation. I would say to Mr. Laurin to be careful with the temple sellers...I mean Wall Street brokers. Everybody would like to see PLI on the Nasdak exchange, but it could become a trap for PLI. My fear; to be taken over under 20 or 25 dollars when we know that PBI 4050 could value more than that by itself before the consolidation. The shark pool is just in front of us.
Bullboard Posts